61
Participants
Start Date
May 19, 2023
Primary Completion Date
January 31, 2026
Study Completion Date
July 31, 2027
Elacestrant
Starting dose 400 mg elacestrant dihydrochloride administered orally once daily for an estimated 6 months of treatment.
Cancer Research Centre, Tbilisi
Innova Medical Center, Tbilisi
LTD Simon Khechinashvili University Clinic, Tbilisi
Multiprofile Clinic Consilium Medulla, Tbilisi
Complex Oncology Center, Plovdiv
Unidad Médica Onco-Hematológica, Puebla City
Fucam, Ac., Mexico City
COC Veliko Tarnovo, Veliko Tarnovo
COMPLEX ONCOLOGICAL CENTER - Shumen, Shumen
Morton Plant Hospital - Baycare Health System, Clearwater
The Toledo Clinic, Toledo
Inventa Center for Cancer Research at Fort Wayne Medical Oncology and Hematology, Fort Wayne
Northwestern University, Northwestern Feinberg School of Medicine Prentice Women's Hospital, Chicago
I CAN Oncology Center, Centro Medico AVE, Monterrey
Alliance for Multispecialty Research, Merriam
Highlands Oncology Group, PA, Springdale
UT Health San Antonio Mays Cancer Center, San Antonio
University of Colorado Cancer Center, Aurora
Comprehensive Cancer Centers of Nevada, Las Vegas
Hospital de Clinicas de Porto Alegre, Porto Alegre
OPN Healthcare, Arcadia
Quality Cancer Care Alliance (QCCA) Northwest Medical Specialties, Tacoma
"Centrul de Oncologie Sf. Nectarie", Craiova
"Institutul Oncologic Prof. Dr. Ion Chiricuta Cluj Napoca", Cluj-Napoca
Centro de Pesquisas Clinicas em Oncologia (Center for Clinical Research in Oncology (CPCO)) - Hospital Evangélico de Cachoeiro de Itapemirim, Cachoeiro de Itapemirim
Hospital São Lucas PUCRS - Centro de Pesquisa em Oncologia (CPO), Porto Alegre
Centro De Pesquisa Clinica DO Hospital Sirio-Libanes - UNIDADE Brasilia, Brasília
Centro de Pesquisas Oncologicas, Florianópolis
Hospital de Amor de Barretos, Barretos
Centro de Estudos e Pesquisas de Hematologia e Oncologia- CEPHO, Santo André
Clinica de Pesquisas e Centro de Estudos Em Oncologia Ginecologica e Mamaria Ltda, São Paulo
Institute of Clinical Oncology, Tbilisi
Todua Clinic, Tbilisi
Torre Medica Hospital Dalinde, Mexico City
Stemline Therapeutics, Inc.
INDUSTRY